Samuel Szomstein, MD

• Center and Surgeon of Excellence of The American Society of Metabolic and Bariatric Surgery (ASMBS)
• Center and Surgeon of Excellence of The American College of Surgeons (ACS)
• Full accreditation by The Fellowship Council in Minimally Invasive and Bariatric Surgery

• Physician of the Year Award, by Cleveland Clinic Hospital in the category of Service. March 2004.
• Physician of the Quarter Award, by Cleveland Clinic Hospital in the category of Growth. 3rd Quarter 2003.
• Physician's Recognition Award, by The American Medical Association, March 2003.
• Certificate of Excellence, by the Cleveland Clinic Florida Operating Room Operations Committee, for outstanding performance and exceptional commitment to the efficiency of the operating room. April 2007.
• Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide.(Rectal desimpactor device) June 2007.
• Innovator Award, by Cleveland Clinic for commitment to bring new technology to patients worldwide.(Bariatric orogastric anastomotic suturing tube and Esophageal double suction isolator tube) June 2006.
• America's Top Surgeons, by the Consumers Research Council of America. 2004-2005 edition. Washington, DC.
• America's Top Surgeons, by the Consumers Research Council of America. 2005-2006 edition. Washington, DC.
• Leadership Award, voted by fellow residents and attendings of The New York Hospital of Queens for the greatest contribution to the quality and life of the residency program, July 2001.

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-11-04, Dr. Szomstein has reported the financial relationships with the companies listed below.

Consulting and/or Speaking. Dr. Szomstein receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Lilly USA, LLC
• Medtronic plc
• Intuitive Surgical, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.